 |
|
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
 |
 |
|
|
|
|
|
|
|
|
|
| 9/9/2010 |
Drug Compound May Bode Well For Treating Alzheimer's Disease
(Chicago, IL) -- A new drug compound is showing some early promise in combating the devastating effects of Alzheimer's disease. Researchers at the University of California San Diego School of Medicine say the drug changes how the enzyme gamma secretase works without completely blocking it. Scientists say it prevented toxic clumps from forming in the brains of mice. Gamma secretase blockers are being developed to stave off the formation in the brain of a protein called beta amyloid. Clumps of the substance kill brain cells and erase thinking and memory in Alzheimer's sufferers. Researchers have had the task of developing ways to keep bad proteins or plaque from occurring without interfering with essential brain functions. The new study on the substance called compound 4 has led to a patent licensing by Neurogenetic Pharmaceuticals. Scientists hope to eventually test the compound in humans. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|